Cello Group PLC | Ownership
Companies that own Cello Group PLC
Liontrust Investment Partners LLP
13,597,344
12.99%
1,037,921
0.31%
08/21/2018
Ennismore Fund Management Ltd.
9,912,176
9.47%
2,064,846
2.33%
02/28/2017
Miton Asset Management Ltd.
8,594,864
8.21%
1,738,622
0.36%
02/28/2017
Investec Wealth & Investment Ltd.
5,956,000
5.69%
-640,000
0.07%
08/01/2018
FIL Investment Advisors (UK) Ltd.
5,786,818
5.53%
3,725,818
0.01%
07/19/2018
BlackRock Investment Management (UK) Ltd.
5,670,384
5.42%
1,424,384
0%
11/22/2017
Hargreave Hale Ltd.
3,562,000
3.4%
-938,000
0.07%
09/18/2017
Close Asset Management Ltd.
3,236,513
3.09%
-294,458
0.12%
02/28/2017
Rowan Dartington & Co. Ltd. (Broker)
2,997,000
2.86%
10,000
0.67%
08/01/2018
Smith & Williamson Investment Management LLP
2,299,000
2.2%
65,000
0.06%
08/01/2018
| Address |
11-13 Charterhouse Buildings
London London & South East EC1M 7AP
United Kingdom
|
|
Employees
|
- |
| Website |
http://cellogroup.co.uk |
| Updated |
07/08/2019 |
| Cello Health Plc is a global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors. It operates through two segments: Cello Health and Cello signal. The Cello Health segment provides market research, consulting, and communications services principally to its pharmaceutical and healthcare clients. |
